One survey of QOL in French testicular cancer survivors with a median survival of 11 years found no difference in scores for pain between patients and controls.144 In a larger study of 1409 testicular cancer survivors with median 11 years of follow-up, survivors reported more bodily pain than controls, and this was statistically but not clinically ignificant. Approximately, 15% of patients reported peripheral sensory neuropathy, and 20% reported Raynaud's phenomenon. Patients who had received chemotherapy were more likely to report neuropathy or Raynaud's syndrome.145 Another study of 277 survivors found that patients who reported Raynaud's (cold white fingers) were more likely to report leg pain (p < 0.01) and other constitutional symptoms.146

0 0

Post a comment